Introduction makes SANYO a Leading Player in Equipping the Stem Cell Therapy Industry

North America Corporation (SANYO) announces that its Biomedical Solutions Division is moving to the forefront of the stem cell and cell therapy market with the introduction of the industry’s first integrated, stand-alone Cell Processing Work Station (CPWS), becoming a significant solutions provider in this high growth, high opportunity marketplace. Offering a turnkey and standalone solution, SANYO’s CPWS is an innovative, cost effective and space-saving solution for the GMP compliant processing and manufacture of regenerative stem cell and cell therapies. The CPWS lowers barriers to enter the cell therapeutics market, positively impacting both public and private institutions. The workstation provides the required class-100 aseptic environment, but in a compact and less expensive than a traditional costly and large footprint cleanroom.

The cell therapy market is increasingly playing an important role in the practice of medicine, and the number of companies and entities that are involved in cell therapy are on the rise, including academic institutions, and public and private companies. The market is expected to expand over the next decade, with applications for the technology to include cancer, cardiac and genetic disorders as well as wounds of the skin and soft tissues.

“SANYO is prepared to expand into this rapidly growing market with its new Cell Processing Work Station, which will provide a practical solution for its biotech and pharmaceutical customers to develop and manufacture advanced cell therapies and hospitals to develop cell therapies for use in clinical trials,” stated Ron Dudek, New Business Development Manager.

Click here to read more on the SANYO CPWS